University of Warwick Wins Domainex’s First Discovery STAR Award
This award will give Professor Fulop access to Domainex’s outstanding drug discovery capabilities to support his research for a much-needed new treatment for Chagas disease - a potentially life-threatening disease.
“Domainex received many strong applications to its Discovery STAR award scheme, but Professor Fulop’s project stood out as he had all the elements needed to start a drug discovery project in this area of unmet medical need,” said Eddy Littler, Chief Executive Officer of Domainex, “We very much look forward to helping Professor Fulop to identify inhibitors of his drug target, and hope that in doing so he will be able to access further funding that will support our joint efforts towards finding a new cure for this terrible disease.”
Domainex will provide Professor Fulop with expert drug discovery guidance and exclusive access to its unique LeadBuilder virtual hit screening technology. Following the identification of hits using this approach, Professor Fulop, who has been working with the University of Warwick’s innovation support team, Warwick Ventures, to take forward his research, will be looking for additional funding to progress his work to identify potential new drug candidates against Chagas disease.
Professor Vilmos Fulop of The University of Warwick said ‘I am absolutely delighted with this award and looking forward to working with Domainex. I regard this collaboration as a starting point towards making significant steps in the finding of a new cure for the treatment of neglected Chagas and the related African sleeping sickness disease.’